BIO-key International, Inc. BKYI
$2.65
-$0.10-3.60%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 6.70M | 6.48M | 5.94M | 6.32M | 6.91M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.70M | 6.48M | 5.94M | 6.32M | 6.91M |
| Cost of Revenue | 1.25M | 1.47M | 1.37M | 1.36M | 1.47M |
| Gross Profit | 5.45M | 5.01M | 4.56M | 4.95M | 5.44M |
| SG&A Expenses | 6.10M | 6.22M | 6.28M | 6.26M | 6.47M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.99M | 10.32M | 10.27M | 10.20M | 10.48M |
| Operating Income | -3.29M | -3.84M | -4.33M | -3.88M | -3.57M |
| Income Before Tax | -6.02M | -6.61M | -7.14M | -4.28M | -4.05M |
| Income Tax Expenses | 16.50K | 16.50K | 16.50K | -23.00K | -23.00K |
| Earnings from Continuing Operations | -6.04 | -6.63 | -7.16 | -4.25 | -4.03 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.04M | -6.63M | -7.16M | -4.25M | -4.03M |
| EBIT | -3.29M | -3.84M | -4.33M | -3.88M | -3.57M |
| EBITDA | -2.99M | -3.52M | -3.98M | -3.51M | -3.18M |
| EPS Basic | -6.83 | -8.28 | -9.65 | -9.60 | -12.05 |
| Normalized Basic EPS | -2.58 | -3.48 | -4.34 | -6.05 | -7.58 |
| EPS Diluted | -6.83 | -8.28 | -9.65 | -9.60 | -12.05 |
| Normalized Diluted EPS | -2.58 | -3.48 | -4.34 | -6.05 | -7.58 |
| Average Basic Shares Outstanding | 3.66M | 3.21M | 2.64M | 2.01M | 1.54M |
| Average Diluted Shares Outstanding | 3.66M | 3.21M | 2.64M | 2.01M | 1.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |